Clinical study of eculizumab with or with not tacrolimus in the treatment of generalized myasthenia gravis
Introduction Eculizumab, an antibody that inhibits the complement system, and the immunosuppressant Tacrolimus are both authorized for treating patients with generalized myasthenia gravis (GMG). This study seeks to evaluate and compare the clinical effectiveness of Eculizumab with or with not Tacrolimus in the treatmen...